For: | Wei J, Wu ND, Liu BR. Regional but fatal: Intraperitoneal metastasis in gastric cancer. World J Gastroenterol 2016; 22(33): 7478-7485 [PMID: 27672270 DOI: 10.3748/wjg.v22.i33.7478] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i33/7478.htm |
Number | Citing Articles |
1 |
Joseph Sirody, Amy H. Kaji, Daielle M. Hari, Kathryn T. Chen. Patterns of gastric cancer metastasis in the United States. The American Journal of Surgery 2022; 224(1): 445 doi: 10.1016/j.amjsurg.2022.01.024
|
2 |
Fu-Chun Huo, Zhi-Man Zhu, Wen-Tao Zhu, Qiu-Ying Du, Jia Liang, Jie Mou. METTL3-mediated m6A methylation of SPHK2 promotes gastric cancer progression by targeting KLF2. Oncogene 2021; 40(16): 2968 doi: 10.1038/s41388-021-01753-1
|
3 |
Cong Luo, Yang Tao, Yuwei Zhang, Yinyin Zhu, Derry Ng Minyao, Maria Haleem, Changzheng Dong, Lina Zhang, Xiaohong Zhang, Jinshun Zhao, Qi Liao. Regulatory network analysis of high expressed long non-coding RNA LINC00941 in gastric cancer. Gene 2018; 662: 103 doi: 10.1016/j.gene.2018.04.023
|
4 |
Yuxin Zhong, Jing Zhang, Xiaofeng Bai, Yuemin Sun, Hao Liu, Shuai Ma, Yang Li, Wenzhe Kang, Fuhai Ma, Weikun Li, Yantao Tian. <p>Lobaplatin in Prophylactic Hyperthermic Intraperitoneal Chemotherapy for Advanced Gastric Cancer: Safety and Efficacy Profiles</p>. Cancer Management and Research 2020; : 5141 doi: 10.2147/CMAR.S249838
|
5 |
Si-Qi Ding, Xue-Ping Zhang, Jun-Peng Pei, Xiao Bai, Jin-Jie Ma, Chun-Dong Zhang, Dong-Qiu Dai. Role of N6-methyladenosine RNA modification in gastric cancer. Cell Death Discovery 2023; 9(1) doi: 10.1038/s41420-023-01485-z
|
6 |
Minkyu Jung, Yanping Yang, Jaclyn E. McCloskey, Marjan Zaman, Yogindra Vedvyas, Xianglan Zhang, Dessislava Stefanova, Katherine D. Gray, Irene M. Min, Raza Zarnegar, Yoon Young Choi, Jae-Ho Cheong, Sung Hoon Noh, Sun Young Rha, Hyun Cheol Chung, Moonsoo M. Jin. Chimeric Antigen Receptor T Cell Therapy Targeting ICAM-1 in Gastric Cancer. Molecular Therapy - Oncolytics 2020; 18: 587 doi: 10.1016/j.omto.2020.08.009
|
7 |
Naiqing Ding, Zhengyun Zou, Huizi Sha, Shu Su, Hanqing Qian, Fanyan Meng, Fangjun Chen, Shiyao Du, Shujuan Zhou, Hong Chen, Lianru Zhang, Ju Yang, Jia Wei, Baorui Liu. iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer. Nature Communications 2019; 10(1) doi: 10.1038/s41467-019-09296-6
|
8 |
M. D. Ray. Multidisciplinary Approach to Surgical Oncology Patients. 2021; : 325 doi: 10.1007/978-981-15-7699-7_40
|
9 |
Paolo Aurello, Niccolò Petrucciani, Laura Antolino, Diego Giulitti, Francesco D'Angelo, Giovanni Ramacciato. Follow-up after curative resection for gastric cancer: Is it time to tailor it?. World Journal of Gastroenterology 2017; 23(19): 3379-3387 doi: 10.3748/wjg.v23.i19.3379
|
10 |
Hiroyuki Arai, Satoru Iwasa, Narikazu Boku, Masahiro Kawahira, Hirofumi Yasui, Toshiki Masuishi, Kei Muro, Keiko Minashi, Shuichi Hironaka, Naoki Fukuda, Daisuke Takahari, Takako Eguchi Nakajima. Fluoropyrimidine with or without platinum as first-line chemotherapy in patients with advanced gastric cancer and severe peritoneal metastasis: a multicenter retrospective study. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5720-3
|
11 |
Jinglei Qu, Xin He, Ying Luo, Ping Yu, Ying Chen, Jing Liu, Xin Wang, Chang Wang, Tingting Liang, Yuxian Bai, Yu Han, Li Man, Chuanchun Leng, Caiyun Zhou, Lijie He, Xin Wang, Yunpeng Liu, Xiujuan Qu. Evaluation of second-line apatinib plus irinotecan as a treatment for advanced gastric adenocarcinoma or gastroesophageal conjunction adenocarcinoma: a prospective, multicenter phase II trial. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1072943
|
12 |
Li-Qun Ren, Qi Li, Yang Zhang. Luteolin Suppresses the Proliferation of Gastric Cancer Cells and Acts in Synergy with Oxaliplatin. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/9396512
|
13 |
Zhiqiang Wang, Gongxing Chen, Qilong Wang, Wei Lu, Meidong Xu. Identification and validation of a prognostic 9-genes expression signature for gastric cancer. Oncotarget 2017; 8(43): 73826 doi: 10.18632/oncotarget.17764
|
14 |
Lukas F. Liesenfeld, Benedikt Wagner, H. Christian Hillebrecht, Maik Brune, Christoph Eckert, Johannes Klose, Thomas Schmidt, Markus W. Büchler, Martin Schneider. HIPEC-Induced Acute Kidney Injury: A Retrospective Clinical Study and Preclinical Model. Annals of Surgical Oncology 2022; 29(1): 139 doi: 10.1245/s10434-021-10376-5
|
15 |
Jieheng Lin, Jianying Yang, Wenping Wang, Xiaotong Lin, Yang Cao. Clinical Complete Remission of An Advanced Gastric Adenocarcinoma After Camrelizumab Plus Chemotherapy Followed by Camrelizumab Plus Capecitabine: A Case Report. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.775147
|
16 |
Emerson Lucena da Silva, Felipe Pantoja Mesquita, Adrhyann Jullyanne de Sousa Portilho, Emanuel Cintra Austregésilo Bezerra, Julio Paulino Daniel, Elenn Suzany Pereira Aranha, Sarah Farran, Marne Carvalho de Vasconcellos, Maria Elisabete Amaral de Moraes, Caroline Aquino Moreira-Nunes, Raquel Carvalho Montenegro. Differences in glucose concentration shows new perspectives in gastric cancer metabolism. Toxicology in Vitro 2022; 82: 105357 doi: 10.1016/j.tiv.2022.105357
|
17 |
Min Shi, Zhongyin Yang, Sheng Lu, Wentao Liu, Zhentian Ni, Xuexin Yao, Zichen Hua, Runhua Feng, Yanan Zheng, Zhenqiang Wang, Birendra Kumar Sah, Mingmin Chen, Zhenglun Zhu, Changyu He, Chen Li, Jun Zhang, Chao Yan, Min Yan, Zhenggang Zhu. Oxaliplatin plus S-1 with intraperitoneal paclitaxel for the treatment of Chinese advanced gastric cancer with peritoneal metastases. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-09027-5
|
18 |
Beihui Xue, Jia Jiang, Lei Chen, Sunjie Wu, Xuan Zheng, Xiangwu Zheng, Kun Tang. Development and Validation of a Radiomics Model Based on 18F-FDG PET of Primary Gastric Cancer for Predicting Peritoneal Metastasis. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.740111
|
19 |
Shin Saito, Hironori Yamaguchi, Hideyuki Ohzawa, Hideyo Miyato, Rihito Kanamaru, Kentaro Kurashina, Yoshinori Hosoya, Alan Kawarai Lefor, Naohiro Sata, Joji Kitayama. Intraperitoneal Administration of Paclitaxel Combined with S-1 Plus Oxaliplatin as Induction Therapy for Patients with Advanced Gastric Cancer with Peritoneal Metastases. Annals of Surgical Oncology 2021; 28(7): 3863 doi: 10.1245/s10434-020-09388-4
|
20 |
Nannan Liu, Yun Wu, Weipeng Cheng, Yuxuan Wu, Liguo Wang, Liwei Zhuang. Identification of novel prognostic biomarkers by integrating multi-omics data in gastric cancer. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08210-y
|
21 |
YuQin Sun, YueQing Chen, Wei Zhuang, ShunYong Fang, QiuXian Chen, MingQiao Lian, ChenBin Lv, JianMing Weng, Ran Wei, Yao Lin, LiSheng Cai, QingShui Wang. Gastric cancer peritoneal metastasis related signature predicts prognosis and sensitivity to immunotherapy in gastric cancer. Journal of Cellular and Molecular Medicine 2023; doi: 10.1111/jcmm.17922
|
22 |
Yosuke Tanaka, Fumiko Chiwaki, Shinya Kojima, Masahito Kawazu, Masayuki Komatsu, Toshihide Ueno, Satoshi Inoue, Shigeki Sekine, Keisuke Matsusaki, Hiromichi Matsushita, Narikazu Boku, Yae Kanai, Yasushi Yatabe, Hiroki Sasaki, Hiroyuki Mano. Multi-omic profiling of peritoneal metastases in gastric cancer identifies molecular subtypes and therapeutic vulnerabilities. Nature Cancer 2021; 2(9): 962 doi: 10.1038/s43018-021-00240-6
|
23 |
V. A. Solodkiy, D. K. Fomin, S. V. Goncharov, S. A. Kukushkina. Modern approaches to the treatment of peritoneal carcinomatosis from gastric cancer (literature review). Siberian journal of oncology 2022; 21(1): 122 doi: 10.21294/1814-4861-2022-21-1-122-129
|
24 |
Zhong-Yin Yang, Fei Yuan, Sheng Lu, Wei Xu, Jun-Wei Wu, Wen-Qi Xi, Min Shi, Zhen-Qiang Wang, Zhen-Tian Ni, Chang-Yu He, Xue-Xin Yao, Ya-Nan Zheng, Zheng-Lun Zhu, Wen-Tao Liu, Jun Zhang, Huan Zhang, Chen Li, Chao Yan, Min Yan, Zheng-Gang Zhu. Efficacy and Safety of Conversion Therapy by Intraperitoneal and Intravenous Paclitaxel Plus Oral S-1 in Gastric Cancer Patients With Peritoneal Metastasis: A Prospective Phase II Study. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.905922
|
25 |
Marta Tkacz, Maciej Tarnowski, Agata Poniewierska-Baran, Karol Serwin, Anna Madej-Michniewicz, Anna Deskur, Bogusław Czerny, Teresa Starzyńska. Impact of Selected Serum Factors on Metastatic Potential of Gastric Cancer Cells. Diagnostics 2022; 12(3): 700 doi: 10.3390/diagnostics12030700
|
26 |
Volkan Kizilgoz, Mecit Kantarci, Gokhan Tonkaz, Akin Levent, Hayri Ogul. Incidental findings on prostate MRI: a close look at the field of view in this anatomical region. Acta Radiologica 2023; 64(4): 1676 doi: 10.1177/02841851221131243
|
27 |
Jianing Yan, Yongfu Shao, Haoxuan Lu, Qihua Ye, Guoliang Ye, Junming Guo. Hsa_circ_0001020 Serves as a Potential Biomarker for Gastric Cancer Screening and Prognosis. Digestive Diseases and Sciences 2022; 67(8): 3753 doi: 10.1007/s10620-021-07211-y
|
28 |
Lisi Zeng, Quanxing Liao, Xiaohui Zeng, Jiacai Ye, Xianzi Yang, Siyu Zhu, Hongsheng Tang, Gaojie Liu, Weiwen Cui, Shaohua Ma, Shuzhong Cui. Noncoding RNAs and hyperthermic intraperitoneal chemotherapy in advanced gastric cancer. Bioengineered 2022; 13(2): 2623 doi: 10.1080/21655979.2021.2021348
|
29 |
Ali Alemdar, Mehmet Güray Duman, Selma Şengiz Erhan, Ali Güner, İsmayil Yılmaz. Extensive Peritoneal Lavage (EIPL) with Saline After Curative D2 Gastric Resection For Treatment of Locally Advanced Gastric Cancer Patients. The Journal of Tepecik Education and Research Hospital 2023; 33(1): 85 doi: 10.4274/terh.galenos.2022.82997
|
30 |
Katarzyna Gęca, Karol Rawicz-Pruszyński, Jerzy Mielko, Radosław Mlak, Katarzyna Sędłak, Wojciech P. Polkowski. Rapid Detection of Free Cancer Cells in Intraoperative Peritoneal Lavage Using One-Step Nucleic Acid Amplification (OSNA) in Gastric Cancer Patients. Cells 2020; 9(10): 2168 doi: 10.3390/cells9102168
|
31 |
Hiroyuki Arai, Yu Sunakawa, Takako Eguchi Nakajima. Co-operative groups in the development of chemotherapy for gastric cancer. Japanese Journal of Clinical Oncology 2019; 49(3): 210 doi: 10.1093/jjco/hyy176
|
32 |
Zhen Wang, Jun-qiang Chen, Jin-lu Liu, Lei Tian. Issues on peritoneal metastasis of gastric cancer: an update. World Journal of Surgical Oncology 2019; 17(1) doi: 10.1186/s12957-019-1761-y
|
33 |
Hiroyuki Arai, Masahiro Kawahira, Hirofumi Yasui, Toshiki Masuishi, Kei Muro, Takako Eguchi Nakajima. Second-line chemotherapy using taxane in patients with advanced gastric cancer who presented with severe peritoneal metastasis: a multicenter retrospective study. International Journal of Clinical Oncology 2021; 26(2): 355 doi: 10.1007/s10147-020-01802-x
|
34 |
Su Shao, Xue Yang, You-Ni Zhang, Xue-Jun Wang, Ke Li, Ya-Long Zhao, Xiao-Zhou Mou, Pei-Yang Hu. Oncolytic Virotherapy in Peritoneal Metastasis Gastric Cancer: The Challenges and Achievements. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.835300
|
35 |
Zhixing Ge, Junhua Zhao, Haibo Yu, Wenguang Yang, Peilin Zhou, Zhenning Wang, Lianqing Liu. Biomimetic construction of peritoneum to imitate peritoneal metastasis using digital micromirror device-based optical projection lithography. Lab on a Chip 2020; 20(17): 3109 doi: 10.1039/D0LC00361A
|
36 |
Leela Rani Avula, Brendan Hagerty, Christine Alewine. Molecular mediators of peritoneal metastasis in pancreatic cancer. Cancer and Metastasis Reviews 2020; 39(4): 1223 doi: 10.1007/s10555-020-09924-4
|
37 |
Luai Al-Marzouki, Vivian S. Stavrakos, Sanjima Pal, Betty Giannias, France Bourdeau, Roni Rayes, Nicholas Bertos, Sara Najmeh, Jonathan D. Spicer, Jonathan Cools-Lartigue, Swneke D. Bailey, Lorenzo Ferri, Veena Sangwan. Soluble factors in malignant ascites promote the metastatic adhesion of gastric adenocarcinoma cells. Gastric Cancer 2023; 26(1): 55 doi: 10.1007/s10120-022-01338-1
|